CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy
2020 · Computational and Structural Biotechnology Journal · 371 citations
https://doi.org/10.1016/j.csbj.2020.08.031
Z
Zhanjun Li
Jilin University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
193
Papers
3.5K
Citations
32
h-index
84
i10-index
Zhanjun Li is an academic researcher from Jilin University. The author has contributed to research in topics: CRISPR and Genetic Engineering & Epigenetics and DNA Methylation & RNA modifications and cancer. The author has an h-index of 32, co-authored 165 publications.
ORCID: 0000-0001-6914-8589Papers by this author
worksEfficient Generation of Myostatin Gene Mutated Rabbit by CRISPR/Cas9
2016 · Scientific Reports · 143 citations
https://doi.org/10.1038/srep25029
A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR
2020 · Cell Death and Disease · 137 citations
https://doi.org/10.1038/s41419-020-02833-y
Genetically modified pigs are protected from classical swine fever virus
2018 · PLoS Pathogens · 83 citations
https://doi.org/10.1371/journal.ppat.1007193
Large-Fragment Deletions Induced by Cas9 Cleavage while Not in the BEs System
2020 · Molecular Therapy — Nucleic Acids · 82 citations
https://doi.org/10.1016/j.omtn.2020.06.019
Efficient base editing with high precision in rabbits using YFE-BE4max
2020 · Cell Death and Disease · 45 citations
https://doi.org/10.1038/s41419-020-2244-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat